Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh. (TIGR)

May 31, 2024 updated by: University Hospital, Ghent

Recurrence Rate After Primary and Secondary Ventral Hernia Repair Using Long-term Resorbable Versus Non-resorbable Large Pore Synthetic Mesh.

Since abdominal wall hernia repair is currently performed with the use of a mesh, side effects associated with the mesh are frequently reported during long term follow-up. These side effects are related to shrinkage of the mesh, adhesions to the bowl, pain, and inflammation of the skin and bowl. To reduce or prevent these effects, a fully resorbing mesh has been developed, which provides sufficient support and strength to allow efficient recovery of the abdominal wall, but also disappear from your body in three years time, so that you no longer have any synthetic material in your body. Previous resorbing meshes also disappeared but over a much shorter period of time, so that the hernia was insufficiently healed, with recurrence as a result.

The TIGR™ mesh (the resorbable mesh used in the study) is in principle a synthetic mesh, made of two commonly used polymers, however it will retain 50% of its initial strength after six months. This in theory is enough to provide support of the collagen healing process during the initial wound-healing phase, but also to support the transition of initial collagen to functional collagen.

The aim of this study is to compare TIGR™ with large pore mesh used in the repair of the anterior abdominal wall repair (incisional hernia, umbilical hernia, etc..Inguinal hernias are not part of the study).

Therefore the patients will be divided into two groups, one group will be treated with a resorbing mesh, the other group will be treated with a permanent mesh. Otherwise there will be no difference in the medication or the surgical techniques used.

Study Overview

Study Type

Interventional

Enrollment (Actual)

95

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Ghent, Belgium, 9000
        • Ghent University Hospital
      • Leuven, Belgium, 3000
        • University Hospital Leuven
      • Copenhagen, Denmark, DK-2400
        • University of Copenhagen
      • Wejherowo, Poland, 84-200
        • ul Jagalskiego
      • Madrid, Spain
        • Hospital de 12 Octobre
      • Edinburgh, United Kingdom, EH16 4SA
        • Royal Infirmary of Edinburgh

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Primary and secondary ventral hernia

    • less than 20 cm in length
    • less than 6 cm in width

Exclusion Criteria:

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Resorbable mesh
Long-term resorbable mesh implanted to treat primary and secondary ventral hernia.
Surgery for primary and secondary ventral hernia repair with placing of resorbable mesh.
Active Comparator: Non-resorbable mesh
Non-resorbable synthetic mesh implanted to treat primary and secondary ventral hernia.
Surgery for primary and secondary ventral hernia repair with placing of non-resorbable synthetic mesh.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Recurrence rate at 3 years post-surgery.
Time Frame: 3 years post-surgery
Clinical evaluation and ultrasound evaluation after 3 years post-surgery.
3 years post-surgery

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Wound Morbidity 4 weeks post-surgery.
Time Frame: 4 weeks post-surgery
4 weeks post-surgery
Pain and discomfort after 1 year post-surgery.
Time Frame: After 1 year post-surgery
After 1 year post-surgery
Pain and discomfort after 3 years post-surgery.
Time Frame: After 3 years post-surgery
After 3 years post-surgery
Recurrence rate by clinical examination 1 year post-surgery.
Time Frame: After 1 year post-surgery.
Clinical Examination to determine the recurrence rate.
After 1 year post-surgery.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Investigators

  • Principal Investigator: Frederik Berrevoet, MD, PhD, University Hospital, Ghent

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2013

Primary Completion (Actual)

August 1, 2021

Study Completion (Actual)

December 31, 2023

Study Registration Dates

First Submitted

June 15, 2012

First Submitted That Met QC Criteria

June 18, 2012

First Posted (Estimated)

June 19, 2012

Study Record Updates

Last Update Posted (Actual)

June 3, 2024

Last Update Submitted That Met QC Criteria

May 31, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary and Secondary Ventral Hernia

Clinical Trials on Placing the resorbable mesh

Subscribe